Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Appendiceal Neoplasms × nintedanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Sarcoma 1 Radiation Pneumonitis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Inflammatory Breast Neoplasms 1 Breast Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Oxaliplatin 2 nintedanib 1 motexafin lutetium 1 Palonosetron 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03287947 2022-08-09

LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma

Wake Forest University Health Sciences

Phase 2 Terminated

5 enrolled 12 charts

Gastrointestinal

Appendiceal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡